Why Shares of CymaBay Therapeutics Are Soaring Friday

A competitor's drug had a so-so phase 3 trial, lifting the possibilities for CymaBay's lead therapy.

Related Keywords

Japan ,Raymond James ,Harish Shantharam ,Steven Seedhouse ,Ed Arce ,Hc Wainwright Co ,Drug Administration ,Cymabay Therapeutics ,Kaken Pharmaceutical ,